United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, co...
Researchers are now increasingly examining mental health as the product of interactions among the nervous, immune, metab...
The success of mRNA vaccines during the COVID-19 pandemic transformed the technology from a promising scientific approac...
Cellares, US-based Integrated Development and Manufacturing Organisation (IDMO), and Seoul National University Hospital ...
NUS Enterprise, the entrepreneurial heart of the National University of Singapore, has unveiled its next chapter as NUSX...
The University of Melbourne has joined the Structural Genomics Consortium (SGC) with the establishment of SGC-Melbourne,...
Bio-Techne Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the o...
Researchers from Birla Institute of Technology and Science, Pilani (BITS Pilani), India and institutions in Taiwan have ...
An Australian-first cancer research facility that will allow scientists to examine individual cancer and immune cells in...
The latest personalised mRNA cancer vaccine data have renewed attention on individualized oncology. How significant is t...
As Asia-Pacific’s manufacturing landscape becomes more sophisticated, purification and separation technolo...
South Korea-based 1ST Biotherapeutics, Inc. and SK Biopharmaceuticals have entered into an exclusive global li...
To further enhance Taiwan’s role in global clinical research and innovative drug development, accelerate the advan...
South Korea-based NAVER D2SF, NAVER's inhouse corporate venture arm, has invested in ImpriMed, a Silicon Valley-based pr...
Akeso has received clearance from the Center for Drug Evaluation under China’s National Medical Products Administr...
Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy&...
GSK plc has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) from Chimagen Bio...
Sichuan Kelun-Biotech Biopharmaceutical has reported published Phase III results for trastuzumab botidotin in patients w...
Johnson & Johnson has reported final overall survival results from the Phase III PAPILLON study evaluating first-lin...
Indian biopharma firm Biocon has announced the signing of partnership agreement with Bahiafarma and Bionovis for Pe...
Teijin Limited, Teijin Regenet Co., Ltd., and Shinshu University Hospital have entered into a joint research agreement r...
China Medical System Holdings has announced that initial prescriptions for Silevimig Injection have been issued at multi...
Indian biotechnology company Immunoscript Life Science will receive up to $8.9 million from Norway-based Coalition for E...
BioSpectrum Asia has published The CEO Handbook 2026, a seventy two page Career Spotlight edition profiling fifty chief ...
Korea Advanced Institute of Science and Technology (KAIST) has partnered with Thermo Fisher Scientific to establish SHAR...
